1 BETA-CELL FAILURE IN DIABETES AND PRESERVATION BY ...
1 BETA-CELL FAILURE IN DIABETES AND PRESERVATION BY ...
1 BETA-CELL FAILURE IN DIABETES AND PRESERVATION BY ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
11<br />
extent of,but does not prevent, islet amyloid deposition in mice expressing the gene for<br />
human islet amyloid polypeptide . Diabetes 54 :2235-2244<br />
125. Lupi R,Del Guerra S,Marselli L,Bugliani M,Boggi U,Mosca F,Marchetti P,Del Prado<br />
S 2004 Rosiglitazone prevents the impairment of human islet function induced by fatty<br />
acids:evidence for a role of PPARγ 2 in the modulation of insulin secretion Am J Physiol<br />
Endocrinol Metab 286:E560-E567.<br />
126. Marselli L,Bambini MC,Lupi R,Del Guerra S,Boggi U,Mosca F,Del Prado<br />
S,Marchetti P 2002 Rosiglitazone partially prevents free fatty acid-induced cytotoxicity<br />
in human pancreatic islet cell [Abstract 494] Diabetologia 45(Suppl 2) A 161.<br />
127. Zeender E,Maedler K,Bosco D,Berney T,Donath MY,Halban PA 2004 Pioglitazone<br />
and sodium salicilate protect human β-cells against apoptosis and impaired function<br />
induced by Glucose and Interleukin-1β.Diabetes 89:5059-5066.<br />
128. Lin C-Y,Gurlo T,Haataja L,Hsueh WA,Butler PC 2004 Peroxisome proliferator –<br />
activated receptor (PPAR-γ activation protects human islets from human islet amyloid<br />
polypeptide –induced apoptosis [Abstract 137-OR] Diabetes 53(Suppl 2):A32.<br />
129. Juhl CB,Hollingdal M,Porksen N,Prange A,Lönnqvist F,Smith O 2003 Influence of<br />
rosiglitazone treatment on β-cell function in type 2 diabetes : Evidence of an increased<br />
ability of glucose to entrain high-frequency insulin pulsatility J Clin Endocrinol Metab<br />
88:3794-3800<br />
130. Lebovitz HE,Dole JF,Patwardhan R,Rappaport EB,Freed MI 2001 Rosiglitazone<br />
monotherapy is effective in patients with type 2 diabetes . J Clin Endocrinol Metab<br />
86:280-288.<br />
131. Wolffenbuttel BH,Gomis R,Squatrito S,Jones NP,Patwardhan RN 2000 Addition of<br />
low-dose rosiglitazone to sulphonylurea therapy improves glycemic control in Type 2 dia-<br />
betic patients. Diabet Med 17:40-47.<br />
132. Einhorn D,Rendell M,Rosenzweig J,Egan JW,Mathisen AL,Schneider RL 2000<br />
Pioglitazone hydrochloride in combination with metformin in the treatment of type 2<br />
diabetes : a randomized ,placebo-controlled study.The Pioglitazone 027 Study Group.Clin<br />
Ther 22:1345-1409.<br />
133. Jones TA,Sautter M,Van Gaal LF,Jones NP 2003 Addition of rosiglitazone to<br />
metformin is most effective in obese,insulin-resistant patients with type 2 diabetes.<br />
Diabetes Obes Metab 5:163-170.<br />
134. Rosenblatt S,Miskin B,Glazer NB,Prince MJ,Robertson KE 2001 The impact of<br />
pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2<br />
diabetes mellitus. Coron Artery Dis 12:413-423 .